Dana Devine Lab |
||
 |
Katherine Serrano Devine Lab Email me ResearchGate Ph.D. in Biochemistry, University of British Columbia, Canada |
Bio: I am interested in the biology of blood cells (red blood cells and platelets). Together with my colleagues at Canadian Blood Services, Centre for Innovation, I study how we can manufacture and store the best quality blood products for patients in need of blood transfusions. |
Leonard Foster Lab |
||
 |
Queenie W.T. Chan Foster Lab |
|
Bob Hancock Lab |
||
 |
Evan Haney Hancock Lab Email me Ph.D. in Biochemistry, University of Calgary, Canada |
Bio: Many cationic peptides have been shown to exhibit antimicrobial, antibiofilm, antitumour and immunomodulatory activities. I am currently working on optimizing synthetic peptides for various applications and trying to understand what are the peptide sequence requirements that govern these biological activities. Expertise: Synthetic peptides, biophysics, structural biology, high throughput screening. |
 |
Mike Trimble Hancock Lab Email me Ph.D. in Microbiology, Indiana University, USA |
Bio: Bacterial cell division is an attractive target for antimicrobial agents. I am investigating how antimicrobial peptides affect cell division in Pseudomonas aeruginosa. Expertise: Bacterial physiology, bacterial genetics, bacterial cell division, and light microscopy. |
|
John T.J. Cheng Hancock Lab Email me Ph.D. in Chemistry/Physical biochemistry, University of British Columbia, Canada |
Bio: Physical biochemistry, lipid biochemistry, protein biochemistry, peptide chemistry. Expertise: Solution and oriented CD, solution and solid-state NMR, tryptophan fluorescence, dynamic light scattering, DSC, mass spectrometry-based proteomics. |
Hongshen Ma Lab |
||
 |
Kerryn Matthews Ma Lab Email me ResearchGate Ph.D. in (Med.) Immunology, University of Cape Town, South Africa |
Bio: I received my PhD, focused on the immunological profiling of pericardial tuberculosis from the University of Cape Town, South Africa. Since then I have done a Postdoctoral Fellowship in the Department of Mechanical Engineering with Dr. Hongshen Ma, and am now a Research Associate in the same group. Our current research areas include 1) the development of new technologies for cell sorting, cell biomechanics, single cell sequencing, chemotaxis, and drug screening; as well as 2) the application of these technologies to study circulating tumor cells, personalize cancer therapies, evaluate blood quality, and expedite antimalarial drug development. |
Chris Overall Lab |
||
 |
Georgina Butler Overall Lab Email me Lab website ResearchGate Ph.D. in Biochemistry, University of Leicester, UK |
Bio: I am a Research Associate in the Overall lab. Clinical trials to prevent metastasis by blocking extracellular matrix (ECM) cleavage by matrix metalloproteinases (MMPs) failed: Side-effects suggested that MMPs process other bioactive substrates that have crucial activities. To specifically target disease-related activities of MMPs and other proteases, we need to know not only which substrates are cleaved, but the functions of those substrates before and after cleavage. Finding novel MMP substrates in biological samples is a complex process that can now be tackled by degradomics. Our suite of degradomics techniques identifies protease substrates in biological samples from cells to patients. My focus is moonlighting proteins, i.e. proteins with canonical intracellular roles that are released by cell death and/or secretion where alternative extracellular functions may be modulated by proteolytic processing. Once released, many are implicated in inflammation, innate and autoimmunity, warranting further study in relation to human diseases. Expertise: Matrix metalloproteinases (MMPs), proteolytic processing, biochemistry, cell biology, degradomics, scientific writing, editing. |
Ed Pryzdial Lab |
||
 |
Michael Sutherland Pryzdial Lab Email me Ph.D. in Biochemistry, University of Ottawa, Canada |
Bio: Dr. Michael Sutherland received his PhD from the University of Ottawa, Department of Biochemistry, Microbiology and Immunology in 2003. Since then, Michael has been working with Dr. Ed Pryzdial as a Research Associate with Canadian Blood Services at the UBC Center for Blood Research. The focus of Michael’s research is the modulation of haemostasis by two enveloped viruses: herpes simplex type 1 (HSV1) and dengue virus (DENV). The use of HSV1 has led to identification of novel pathways to initiate coagulation directly on the virus surface. This activation is facilitated by both normal blood proteins and proteins encoded by the virus genome. Ultimately, these pathways may enhance the susceptibility of host cells to infection and contribute to the risk of vascular pathology. Studies with DENV have revealed that DENV can bind and infect platelets with the eventual production of infectious DENV progeny. This provides a possible additional mechanism for the thrombocytopenia that is often seen clinically with DENV infection. Identification of DENV replication within blood cells also have broader implications of other clinically important RNA viruses. In addition to many scientific endeavours, Dr. Sutherland is involved in medical education and currently holds an Adjunct Professor appointment with the Department of Pathology and Laboratory Medicine. Within the UBC Faculty of Medicine, he’s involved in delivery of both the Bachelor of Medical and Laboratory Sciences (BMLSc) and medical undergraduate (MDUP) programs. Working within a variety of pedagogical styles has granted him a unique insight into several methods to convey scientific information. He has also recently been appointed as the Associate Director of the BMLSc program, where he’s involved in education and curriculum development. |